Osteoporosis Drug Romosozumab Gains First Approval, in Japan Osteoporosis Drug Romosozumab Gains First Approval, in Japan

First approval worldwide for anabolic agent romosozumab for osteoporosis in women at high risk of fracture. The FDA previously rejected it, but an advisory committee will discuss the agent in 2 weeks.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news